Evoke Pharma Inc
San Diego, CA · Founded 2007 · CIK 0001403708 · Biotech · Acquired
Oral small molecule therapeutics for diabetic gastroparesis and gastrointestinal disorders
evokepharma.com →- Grants
- —
- No SBIR or STTR on record
- Sector median: 1
- Raised
- $6.0M
- 1 Form D · Jun 2010
- 195 months since last filing
- Contracts
- —
- No federal contracts on record
- Patents
- 30
- 7 granted · 23 pending
- Sector median: 2
Capital Timeline
Federal ↑Equity ↓2010
| Date | Event | Source | Amount |
|---|---|---|---|
| Private capital raised | Form D · SEC | $6,000,001 |
Form D · SEC
Peer position
| # | Company | Contracts | Disclosed equity |
|---|---|---|---|
| 1865 | Tetragenetics, Inc. | — | $7.1M |
| 1866 | Regenerative Medical Solutions Inc | — | $7.0M |
| 1867 | Angarus Therapeutics, Inc. | — | $6.9M |
| 1868 | Evoke Pharma Inc | — | $6.0M |
| 1869 | Kiniksa Pharmaceuticals | — | $5.9M |
| 1870 | Jennerex, Inc. | — | $5.4M |
| 1871 | AKTTYVA THERAPEUTICS, INC. | — | — |
Ranked on federal contract value rather than capital raised. The equity column is the comparison worth making — companies at the same procurement position often sit at very different points in their funding history.
Founders & Team
- Todd BradyDirector
- Matt D'OnofrioExecutive Officer
- Cam GarnerDirector
- Scott GlennDirector
- David GonyerDirector · Executive Officer
- Malcolm HillDirector
- Kenneth WidderDirector
Patents
- Treatment Of Moderate And Severe Gastroparesisapplication
- Reduction Of Healthcare Resource Utilization By Patients Treated With Intranasally-administered Metoclopramideapplication
- Methods For Treating Gastroparesisapplication
- Treatment Of Moderate And Severe Gastroparesisgranted
- Nasal Formulations Of Metoclopramideapplication
- Nasal Formulations Of Metoclopramidegranted
- Nasal Formulations Of Metoclopramidegranted
- Nasal Formulations Of Metoclopramidegranted
- Nasal Formulations Of Metoclopramidegranted
- Treatment Of Moderate And Severe Gastroparesisgranted
- Treatment Of Symptoms Associated With Female Gastroparesisapplication
- Nasal Formulations Of Metoclopramidegranted
Regulatory activity · Biotech
- New Animal Drugs; Approval of New Animal Drug Applications; Withdrawal of Approval of New Animal Drug Application; Change of SponsorFood and Drug Administration
- Medical Devices; General and Plastic Surgery Devices; Classification of the Skin Patch for Treatment of HyperhidrosisFood and Drug Administration
- Medical Devices; Anesthesiology Devices; Classification of the Monitor for Opioid Induced Impairment of OxygenationFood and Drug Administration
- Medical Devices; Orthopedic Devices; Classification of the Medial Knee Implanted Shock AbsorberFood and Drug Administration
- Medical Devices; Neurological Devices; Classification of the External Lower Extremity Nerve Stimulator for Restless Legs SyndromeFood and Drug Administration
- Medical Devices; General Hospital and Personal Use Devices; Classification of the Infant Supine Sleep SystemFood and Drug Administration
Rules are matched to sector, not to company. Recent activity in a sector is context rather than a signal about this business — until rules are matched to what a company actually builds, the section is shown as context and nothing more.